Clinical Trials

 

 

As new technologies and personalized vaccines become the norm, the dynamic of clinical trials has to evolve. This focused clinical development conference will allow you to showcase your services to those who are looking to run new trial models, need support in choosing and gaining approval for different clinical endpoints and want to understand how to get the best out of the information collected.

 

Who Attends

 

• Pharma
• Biotech
• National and International Government
• Academics And Research Institutions

 

Job Titles

 

• CEO / CSO / COO
• CMO / Head of Scientific Affairs
• Head of Clinical Development
• Head of Clinical Trial Management / Operations
• Head of R&D

Who Should Sponsor?

 

• CROs
• OEMs / Equipment Manufacturers
• Platform Technology Providers
• Big Pharma
• Biotech

 

 

Clinical Development and Trials Conference, Tuesday 16 April 2019

Panel discussion
Cynthia Dukes
Clinical Development and Trials Conference
10:10

Seasonal influenza vaccine efficacy studies: Lessons learned from 3 global studies

10:40

Networking Coffee Break

Clinical Development and Trials Conference
11:40

Overcoming challenges in seasonal vaccine studies

Adrian Wildfire
Clinical Development and Trials Conference
12:10

Conceptualizing issues around routes of inoculation VS immunological response

Wayne Hogrefe
Clinical Development and Trials Conference
12:40

Comparison of Zika Virus Neutralization Assay Platforms: PRNT and RVP

Wayne Hogrefe, Vice President, Vaccines, Q² Solutions
Laurent Duroux
Clinical Development and Trials Conference
12:55

NanoQuil - a novel next-generation saponin adjuvant

13:10

Networking Lunch & Poster Session

Jakub Simon
Clinical Development and Trials Conference
15:40

Correlates of Protection in Vaccine Clinical Development

-From Model Fitting to Machine Learning
16:09

Networking Coffee Break

Thomas Richie
Clinical Development and Trials Conference
16:40

Frontiers in controlled human malaria infection (CHMI): accelerating malaria vaccine development, use in HIV+ populations, and empowering malaria research in Africa

-Aseptic, purified, cryopreserved sporozoites for CHMI (“challenge in a bottle”)-Expansion of research capabilities in Africa-Ethical considerations of CHMI in HIV+ populations
Anna Durbin
Clinical Development and Trials Conference
17:10

How do we move forward in Zika vaccine development using the Human Challenge Model

-Bioethics of using the human challenge model-Background information on the original report for zika vaccine development-Epidemiology of zika today-How has the landscape changed
Panel discussion
Clinical Development and Trials Conference
17:40

The “how’s” of Human Challenge Model studies (CHIMS)

-How are the studies done?-How are the models developed and used?-How are CHIMS becoming more commercially used?-Why do subjects volunteer?
Philip Krause, Deputy Director, U.S. Food and Drug Administration
18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, follow the congress team

last published: 14/Dec/18 13:15

 

Clinical Development and Trials Conference, Wednesday 17 April 2019

Annaliesa Anderson
Clinical Development and Trials Conference
10:10

Are bacterial vaccines harder to develop?

  • What are the challenges in clinical efficacy trials?
  • Phase II Clostridium difficile vaccine
10:40

Networking Coffee Break

Grant Pickering
Clinical Development and Trials Conference
11:30

Broad spectrum pneumococcal conjugate vaccines in development

12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 14/Dec/18 13:15

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071